ACOR

Acorda Therapeutics
ACOR

Overview Fund Trends Analyst Outlook Journalist POV
Delisted

ACOR was delisted on the 11th of April, 2024.

Back to rankings

32 hedge funds and large institutions have $18M invested in Acorda Therapeutics in 2021 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 12 increasing their positions, 7 reducing their positions, and 23 closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more capital invested

Capital invested by funds: $ → $

more call options, than puts

Call options by funds: $ | Put options by funds: $

less funds holding

Funds holding: →

61% less first-time investments, than exits

New positions opened: 9 | Existing positions closed: 23

Holders
32
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$1.19M
Puts
$924K
Net Calls
Net Calls Change

Top Buyers

1
+$3.61M
2
+$956K
3
+$650K
4
Jacobs Levy Equity Management
Jacobs Levy Equity Management
New Jersey
+$337K
5
CCM
Chilton Capital Management
Texas
+$311K

Top Sellers

1
-$151K
2
-$81K
3
-$53K
4
Squarepoint
Squarepoint
New York
-$42K
5
California Public Employees Retirement System
California Public Employees Retirement System
California
-$35K
Name Holding Trade Value Shares
Change 		Change in
Stake
26
$2K
27
$1K
28
–
29
–
30
–
31
–
32
–
33
–
34
–
35
–
36
–
37
–
38
–
39
–
40
–
41
–
42
–
43
–
44
–
45
–
46
–
47
–
48
–
1
2